Renowned Podiatric Surgeon Lectures at APMA Annual Scientific Meeting on Evidence Base for EOTTS

Aug. 21, 2012 - PRLog -- Macomb, MI – The National, the American Podiatric Medical Association’s (APMA) Annual Scientific meeting, took place August 16 – 19, 2012 in Washington, DC.  Over 2,000 podiatric medical specialists attended the conference. The association provides podiatric medical professionals exceptional opportunities for continued education and networking and is a leader in advancing the podiatric medical profession.

Podiatric medical professionals from across the nation were invited to attend lectures on a variety of topics regarding the latest advances in their field. During the evidenced-based medicine lecture series, Master HyProCure^® Surgeon, Philip Bresnahan, had the opportunity to lecture on the Science and Benefit/Risk Analysis of Extra-Osseous TaloTarsal Stabilization.

Dr. Bresnahan is a nationally known speaker and author of several medical journal articles. Dr. Bresnahan is also very involved in ongoing clinical research studies. He serves as an assistant Professor in the Department of Podiatric Orthopedics at Temple University School of Podiatric Medicine. Dr. Bresnahan is a member of the American Podiatric Medical Association, Pennsylvania Podiatric Medical Association, the Bucks-Mont Podiatric Medical Association and is a Fellow of the American College of Foot and Ankle Surgery. He has been in private practice for over 20 years.

Dr. Bresnahan’s lecture was well received. “I was grateful to be able to speak to the attendees at APMA and help them fully understand the proven science of the benefits of stabilizing the talotarsal mechanism,” said Bresnahan.

A review on the Benefits and Risks of EOTTS is available through GraMedica^®, a global orthopedic medical device company and distributor of the HyProCure^® talotarsal stabilization device, on their website at www.GraMedica.com.

The HyProCure^® device is a breakthrough treatment option for talotarsal dislocation, a condition affecting people of all ages throughout the world. Via a minimally invasive procedure, HyProCure^® instantly corrects the problem at its root and immediately works on improving and even reversing many of the symptoms and secondary conditions resulting from this common deformity. These include low arches, overpronation, plantar fasciitis or heel pain, knee pain, hip pain, back pain, and many others, both in children and adults.

Working with physicians and local distributors on nearly every continent, GraMedica^® strives to educate foot and ankle professionals on the importance of stabilizing the talotarsal mechanism. GraMedica^® works cooperatively with the Graham International Implant Institute (GIII), which has the mission of elevating the standard of care in the arena of Extra-Osseous TaloTarsal Stabilization through surgeon education.

Foot and ankle surgeons are invited to learn more about the HyProCure^® implant and procedure at http://www.GraMedica.com, where they can also train online and/or find a live surgical training seminar in their area.
 
Potential surgical candidates can find out more about the HyProCure^® solution and the devastating effects of talotarsal displacement at http://www.HyProCure.com. Find a local HyProCure^® specialist through the physician locator at http://hyprocure.com/doctor-locator/.  

Learn more about HyProCure^® and osteo-WEDGETM, GraMedica^®’s latest innovative Bone Locking System at www.GraMedica.com; follow updates on Facebook.com/HyProCure.

Contact:
Susan Doherty, Director, Education & Physician Resources
+1-586-677-9600
sdoherty@grahamiii.com